Ramírez-Vidal, L.; Becerril-Rico, J.; Monroy-Mora, A.; Tinajero-Rodríguez, J.M.; Centeno-Cruz, F.; Oñate-Ocaña, L.F.; Ortiz-Sánchez, E.
Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer. Diagnostics 2024, 14, 1614.
https://doi.org/10.3390/diagnostics14151614
AMA Style
Ramírez-Vidal L, Becerril-Rico J, Monroy-Mora A, Tinajero-Rodríguez JM, Centeno-Cruz F, Oñate-Ocaña LF, Ortiz-Sánchez E.
Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer. Diagnostics. 2024; 14(15):1614.
https://doi.org/10.3390/diagnostics14151614
Chicago/Turabian Style
Ramírez-Vidal, Lizbeth, Jared Becerril-Rico, Alberto Monroy-Mora, Jose Manuel Tinajero-Rodríguez, Federico Centeno-Cruz, Luis F. Oñate-Ocaña, and Elizabeth Ortiz-Sánchez.
2024. "Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer" Diagnostics 14, no. 15: 1614.
https://doi.org/10.3390/diagnostics14151614
APA Style
Ramírez-Vidal, L., Becerril-Rico, J., Monroy-Mora, A., Tinajero-Rodríguez, J. M., Centeno-Cruz, F., Oñate-Ocaña, L. F., & Ortiz-Sánchez, E.
(2024). Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer. Diagnostics, 14(15), 1614.
https://doi.org/10.3390/diagnostics14151614